Cleared Traditional

K900493 - THE PRECISIONIST

K900493 is an FDA 510(k) clearance for THE PRECISIONIST, manufactured by Paradigm Medical, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 207-day FDA review.

K900493 · Paradigm Medical, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1990
Decision
207d
Days
Class 2
Risk

K900493 is an FDA 510(k) clearance for the THE PRECISIONIST. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Paradigm Medical, Inc. (Volcano, US). The FDA issued a Cleared decision on August 28, 1990 after a review of 207 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Paradigm Medical, Inc. devices

FDA 510(k) Submission Details - K900493

510(k) Number K900493 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 1990
Decision Date August 28, 1990
Days to Decision 207 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
97d slower than avg
Panel avg: 110d · This submission: 207d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 194
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K900493.
GEMINI OPHTHALMIC SURGERY SYSTEM
K911808 · Alcon Laboratories · Jun 1991
SITE 19 GAUGE ULTRASONIC I/A PHACO NEEDLE
K904151 · Site Microsurgical Systems, Inc. · Dec 1990
SITE PHACOEMULSIFICATION HANDPIECE
K904183 · Site Microsurgical Systems, Inc. · Dec 1990
NIDEK/PHACO EMULSIFICATION SYSTEM MODEL CV-8000
K901686 · Nidek, Inc. · Jun 1990
SITE PHACO PLUS INFUSION SLEEVE
K892852 · Site Microsurgical Systems, Inc. · Jun 1989
SITE PERISTALTIC CASSETTE
K892911 · Site Microsurgical Systems, Inc. · May 1989